Ingenious eBrain: Global CRISPR/CAS9 Technology Assessments

IN-DEPTH ANALYSIS- CRISPR/CAS9 TECHNOLOGY Over the last few decades, Gene editing emerged with the discovery of CRISPR and its variant Cas9. CRISPR not only gave a new image to gene editing but also elevated the standards for new findings. CRISPR and CRISPR-associated (Cas) genes market is anticipated to hit the whopping value of USD 4.09 billion by 2025. The persuading factor for the blooming growth of CRISPR-Cas system is the progressive gene therapy, disease prevalence, GM crops, grants/funding, etc. There has been a continual development in the gene modification strategy beginning from restriction endonucleases, transgenic breeding, RNAi advances to the currently engineered endonucleases. As of 2017, there were four groups of engineered nucleases being used, namely, meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector-based nucleases (TALENs), and the clustered regularly interspaced short palindromic repeats CRISPR-Cas system. Download

free

sample:

http://www.iebrain.com/reports/healthcare-biotechnology/in-depth-

analysis-crispr-technology/ Table of Contents: 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.

Technology Overview Technology Insights Landscape Overview Research Literature Overview Recent in CRISPR viz. CRISPR/Cpf1, xCas9 etc. White Space Analysis Future of CRISPR Press releases Conference Updates CRISPR: Market Overview CRISPR- Market Determinants CRISPR-Opportunity Vs. Restraints CRISPR: Strategic Analysis SWOT & PEST CRISPR Market Development (2012-2017)

Click here for more insights: Reports About Us: At Ingenious eBrain, we believe that humans assisted with machine intelligence can deliver unparalleled results. Our proprietary in-house tools use the power of AI to deliver the most reliable results in half the time used by traditional methods. The AI assisted workflow allows cost-efficient decision making for even the most challenging problems. Contact Us @ Email Id: services@iebrain.com Contact No: +13474802054

Turn static files into dynamic content formats.

Create a flipbook

Ingenious eBrain: Global CRISPR/CAS9 Technology Assessments

Published on Jun 8, 2018

Ingenious e-Brain Solutions

Over the last few decades, Gene editing emerged with the discovery of CRISPR and its variant Cas9. CRISPR not only gave a new image to gene editing but also elevated the standards for new findings. CRISPR and CRISPR-associated (Cas) genes market is anticipated to hit the whopping value of USD 4.09 billion by 2025. The persuading factor for the blooming growth of CRISPR-Cas system is the progressive gene therapy, disease prevalence, GM crops, grants/funding, etc. There has been a continual development in the gene modification strategy beginning from restriction endonucleases, transgenic breeding, RNAi advances to the currently engineered endonucleases. As of 2017, there were four groups of engineered nucleases being used, namely, meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector-based nucleases (TALENs), and the clustered regularly interspaced short palindromic repeats CRISPR-Cas system.